Haleon plc
Haleon plc (HLNCF) Financial Performance & Income Statement Overview
Analyze Haleon plc (HLNCF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Haleon plc (HLNCF) Income Statement & Financial Overview
Analyze Haleon plc’s HLNCF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.76B | $2.78B | $2.77B | $2.92B |
| Cost of Revenue | $1.23B | $1.03B | $979.00M | $1.08B |
| Gross Profit | $1.53B | $1.75B | $1.80B | $1.84B |
| Gross Profit Ratio | $0.55 | $0.63 | $0.65 | $0.63 |
| R&D Expenses | $78.00M | $76.00M | $73.00M | $71.00M |
| SG&A Expenses | $1.11B | $1.09B | $1.09B | $1.10B |
| Operating Expenses | $1.18B | $1.04B | $1.30B | $1.18B |
| Total Costs & Expenses | $2.41B | $2.08B | $2.28B | $2.26B |
| Interest Income | $22.00M | $12.00M | $9.00M | $22.00M |
| Interest Expense | $111.00M | $90.00M | $96.00M | $97.00M |
| Depreciation & Amortization | $0.00 | $11.00M | $6.00M | $47.75M |
| EBITDA | $399.00M | $716.00M | $502.00M | $702.75M |
| EBITDA Ratio | $0.14 | $0.26 | $0.18 | $0.24 |
| Operating Income | $350.00M | $705.00M | $496.00M | $655.00M |
| Operating Income Ratio | $0.13 | $0.25 | $0.18 | $0.22 |
| Other Income/Expenses (Net) | -$62.00M | -$79.00M | -$90.00M | -$65.00M |
| Income Before Tax | $288.00M | $626.00M | $406.00M | $590.00M |
| Income Before Tax Ratio | $0.10 | $0.23 | $0.15 | $0.20 |
| Income Tax Expense | $66.00M | $127.00M | $93.00M | $149.00M |
| Net Income | $231.00M | $485.00M | $303.00M | $423.00M |
| Net Income Ratio | $0.08 | $0.17 | $0.11 | $0.14 |
| EPS | $0.03 | $0.05 | $0.03 | $0.05 |
| Diluted EPS | $0.03 | $0.05 | $0.03 | $0.05 |
| Weighted Avg Shares Outstanding | $9.13B | $9.12B | $9.18B | $9.20B |
| Weighted Avg Shares Outstanding (Diluted) | $9.18B | $9.12B | $9.21B | $9.20B |
The company's financials show resilient growth, with revenue advancing from $2.92B in Q1 2024 to $2.76B in Q4 2024. Gross profit remained healthy with margins at 55% in Q4 2024 compared to 63% in Q1 2024. Operating income hit $350.00M last quarter, sustaining a consistent 13% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $399.00M. Net income dropped to $231.00M, while earnings per share reached $0.03. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan